Precision Biosciences (DTIL) EBT Margin (QoQ) (2018 - 2026)

Precision Biosciences (DTIL) EBT Margin (QoQ) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Precision Biosciences 178.85 Mn 150.56 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -11,535.00
Dec 31, 2025 21.27 Mn
Sep 30, 2025 -8.95 Mn
Jun 30, 2025 -4.98 Mn
Mar 31, 2025 -6.96 Mn
Dec 31, 2024 137,703.00
Sep 30, 2024 -514,647.00
Jun 30, 2024 4,881.00
Mar 31, 2024 17,849.00
Dec 31, 2023 -11,387.00
Sep 30, 2023 -4,393.00
Jun 30, 2023 9,703.00
Mar 31, 2023 -2,198.00
Dec 31, 2022 7,723.00
Sep 30, 2022 74,823.00
Jun 30, 2022 9,310.00
Mar 31, 2022 -54,672.00
Dec 31, 2021 -39,317.00
Sep 30, 2021 -12,044.00
Jun 30, 2021 14,679.00